Atai Beckley N.V

Atai Beckley N.V

ATAI · Nasdaq

Atai Beckley N.V (ATAI) is a Medical pharmaceuticals company in the Healthcare sector, listed on Nasdaq. This page provides the complete earnings calendar, dividend schedule, and financial data for Atai Beckley N.V in 2026. The next earnings report is expected on November 12, 2026.

Earnings calendar

Next earnings date

12 Nov 2026

In 85 days

EPS estimate

-0.12

Revenue estimate

266.7K

Past earnings

11 Aug 2026
EPS actual
—
estimate -0.11
Revenue actual
—
estimate 770.8K
Price reaction
1d
+2.37%
5d
-2.41%
30d
+4.37%
Sign in to view returns
12 May 2026
EPS actual
-0.08 (+25.1%)
estimate -0.11
Revenue actual
954.0K (+339.4%)
estimate 217.1K
Price reaction
1d
+2.37%
5d
-2.41%
30d
+4.37%
Sign in to view returns
06 Mar 2026
EPS actual
-1.73 (-1,558.8%)
estimate -0.10
Revenue actual
1.1M (+255.3%)
estimate 300.0K
Price reaction
1d
+2.37%
5d
-2.41%
30d
+4.37%
Sign in to view returns
Beat Miss usd

Dividend calendar

No dividend history available.

EPS (Earnings Per Share)

Revenue

Company profile

Atai Beckley NV is a clinical-stage biopharmaceutical company. It engages in the treatment of mental health disorders. The company was founded by Christian Angermayer, Florian Brand, Srinivas Rao and Lars Christian Wilde in June 2018 and is headquartered in Amstelveen, Netherlands.

Sector
Healthcare
Industry
Medical pharmaceuticals
Country
Netherlands
Exchange
Nasdaq
CEO
Srinivas G. Rao
Employees
54
IPO date
18 Jun 2021
ISIN
US04650F1012
Website
ataibeckley.com

Frequently asked questions

When does Atai Beckley N.V (ATAI) next report earnings?

Atai Beckley N.V (ATAI) is scheduled to report earnings on November 12, 2026.

What was Atai Beckley N.V's most recent earnings date?

Atai Beckley N.V (ATAI) last reported earnings on August 11, 2026.

Where is Atai Beckley N.V stock listed?

Atai Beckley N.V (ATAI) is listed on Nasdaq.